Clinical trial
Diagnostic and Prognostic Utility of IL-6 and MMP-7 in Pediatric Immune Mediated Interstitial Lung Disease
NCT07559435 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic and Prognostic Utility of IL-6 and MMP-7 in Pediatric Immune Mediated Interstitial Lung Disease
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 15, 2026
- Completion date
- April 30, 2028
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pediatric immune mediated interstitial lung disease